share_log

HC Wainwright & Co. Reiterates Buy on Niagen Bioscience, Maintains $11 Price Target

Benzinga ·  Mar 31 11:13

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Niagen Bioscience (NASDAQ:NAGE) with a Buy and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 293

Recommended

Write a comment